Becton, Dickinson and Company (BD) has completed the acquisition of Scanwell Health to expand and scale digital at-home medical testing.

Previously, BD collaborated with Scanwell to develop an app which was used with its recently launched Veritor At-Home COVID-19 Test.

Claimed to be the first at-home Covid-19 test, Veritor uses a smartphone camera and app to capture and digitally interpret the test results, while eliminating the human subjectivity.

Scanwell will now become the foundational digital platform and BD intends to develop at-home diagnostic tests for a broad range of infectious diseases that include group A strep, Covid-19/influenza A+B.

BD will also create an additional menu to detect infections and manage chronic diseases.

BD life sciences president Dave Hickey said: “The Covid-19 pandemic has accelerated the shift to new care settings, and BD is ready to deliver a smart, connected at-home diagnostic ecosystem to support traditional and telehealth providers and consumers.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This acquisition will enable us to expand and scale our digital capabilities in-house to speed time to market for transformative at-home solutions now and in the future.”

BD Veritor At-Home COVID-19 Test provides a definitive Positive or Negative digital display of the results.

The Scanwell app can also store and report the test results securely to organisations including public health authorities, schools, and businesses.

BD has not disclosed the financial details of the transaction.

In a separate development, BD announced that Embecta, which will hold the company’s Diabetes Care business after the planned spinoff, will be governed by a nine-person board of directors.